Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Reiteration

Reiteration

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Upgrades

Analysts Cheer Nuvei Post Upbeat Q4; 20%+ Ex-Crypto Organic Growth Validates Its Moats And Market Share Gains

By Anusuya Lahiri
Today, 10:54 PM
Credit Suisse analyst Timothy Chiodo upgrades Nuvei Corp (NASDAQ:NVEI) from Neutral to Outperform and raises the price target from $37 to $45.…

NVEI

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Movers
  • News
  • Price Target
  • Reiteration
  • Top Stories
  • Trading Ideas

5 MongoDB Analysts Are Disappointed: ‘Tepid Growth’ Overshadows Q4 Revenue Beat

By Priya Nigam
Today, 10:54 PM
Shares of MongoDB Inc (NASDAQ: MDB) continued to slide in early trading on Thursday, after the company reported disappointing revenue guidance.

MDB

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Susquehanna Reiterates Positive on Nutanix, Maintains $34 Price Target

By Benzinga Newsdesk
Today, 10:54 PM
Susquehanna analyst Mehdi Hosseini reiterates Nutanix (NASDAQ:NTNX) with a Positive and maintains $34 price target.

NTNX

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Movers
  • News
  • Price Target
  • Reiteration
  • Top Stories
  • Trading Ideas

Asana Rallies Off Q4 Earnings: 6 Analysts Break Down The Report

By Priya Nigam
Today, 10:54 PM
Shares of Asana Inc (NYSE: ASAN) were surging Thursday in the wake of the software platform's fourth-quarter results. Here's what the Street has to say. 

ASAN

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Susquehanna Reiterates Positive on Keysight Techs, Maintains $208 Price Target

By Benzinga Newsdesk
Today, 10:54 PM
Susquehanna analyst Mehdi Hosseini reiterates Keysight Techs (NYSE:KEYS) with a Positive and maintains $208 price target.

KEYS

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Susquehanna Reiterates Neutral on Coherent, Maintains $45 Price Target

By Benzinga Newsdesk
Today, 10:54 PM
Susquehanna analyst Mehdi Hosseini reiterates Coherent (NYSE:COHR) with a Neutral and maintains $45 price target.

COHR

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Stephens & Co. Reiterates Overweight on Noodles, Maintains $7 Price Target

By Benzinga Newsdesk
Today, 10:54 PM
Stephens & Co. analyst Joshua Long reiterates Noodles (NASDAQ:NDLS) with a Overweight and maintains $7 price target.

NDLS

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Cantor Fitzgerald Reiterates Overweight on Jasper Therapeutics, Maintains $6 Price Target

By Benzinga Newsdesk
Today, 10:54 PM
Cantor Fitzgerald analyst Pete Stavropoulos reiterates Jasper Therapeutics (NASDAQ:JSPR) with a Overweight and maintains $6 price target.

JSPR

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Benchmark Reiterates Buy on Ideal Power, Maintains $18 Price Target

By Benzinga Newsdesk
Today, 10:54 PM
Benchmark analyst David Williams reiterates Ideal Power (NASDAQ:IPWR) with a Buy and maintains $18 price target.

IPWR

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Benchmark Reiterates Buy on Noodles, Maintains $10 Price Target

By Benzinga Newsdesk
Today, 10:54 PM
Benchmark analyst Todd Brooks reiterates Noodles (NASDAQ:NDLS) with a Buy and maintains $10 price target.

NDLS

Posts navigation

Previous 1 … 14 15 16 … 272 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service